Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35


Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Cobb LP, Gaillard S, Wang Y, Shih IeM, Secord AA.

Gynecol Oncol Res Pract. 2015 May 12;2:1. doi: 10.1186/s40661-015-0008-z.


Endometriosis-associated Malignancy.

Krawczyk N, Banys-Paluchowski M, Schmidt D, Ulrich U, Fehm T.

Geburtshilfe Frauenheilkd. 2016 Feb;76(2):176-181. Review.


Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis.

Wu RL, Ali S, Bandyopadhyay S, Alosh B, Hayek K, Daaboul MF, Winer I, Sarkar FH, Ali-Fehmi R.

J Cancer Sci Ther. 2015;7(7):258-265.


Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.

Burghaus S, Häberle L, Schrauder MG, Heusinger K, Thiel FC, Hein A, Wachter D, Strehl J, Hartmann A, Ekici AB, Renner SP, Beckmann MW, Fasching PA.

BMC Cancer. 2015 Oct 21;15:751. doi: 10.1186/s12885-015-1821-9.


The Risk of Epithelial Ovarian Cancer of Women With Endometriosis May be Varied Greatly if Diagnostic Criteria Are Different: A Nationwide Population-Based Cohort Study.

Lee WL, Chang WH, Wang KC, Guo CY, Chou YJ, Huang N, Huang HY, Yen MS, Wang PH.

Medicine (Baltimore). 2015 Sep;94(39):e1633. doi: 10.1097/MD.0000000000001633.


Cancer in women after assisted reproductive technology.

Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, Koch L, Smith Y, Stern JE, Ball GD, Schymura MJ.

Fertil Steril. 2015 Nov;104(5):1218-26. doi: 10.1016/j.fertnstert.2015.07.1135.


Effects of fertility drugs on cancers other than breast and gynecologic malignancies.

Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff CL.

Fertil Steril. 2015 Oct;104(4):980-8. doi: 10.1016/j.fertnstert.2015.06.045.


Endometriosis: a high-risk population for major chronic diseases?

Kvaskoff M, Mu F, Terry KL, Harris HR, Poole EM, Farland L, Missmer SA.

Hum Reprod Update. 2015 Jul-Aug;21(4):500-16. doi: 10.1093/humupd/dmv013. Review.


Endometriosis and ovarian cancer risk: a systematic review of epidemiological studies.

Zafrakas M, Grimbizis G, Timologou A, Tarlatzis BC.

Front Surg. 2014 May 8;1:14. doi: 10.3389/fsurg.2014.00014. Review.


Salpingectomy as a means to reduce ovarian cancer risk.

Daly MB, Dresher CW, Yates MS, Jeter JM, Karlan BY, Alberts DS, Lu KH.

Cancer Prev Res (Phila). 2015 May;8(5):342-8. doi: 10.1158/1940-6207.CAPR-14-0293. Review.


An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosis.

Wang KC, Chang WH, Lee WL, Huang N, Huang HY, Yen MS, Guo CY, Wang PH.

BMC Cancer. 2014 Nov 18;14:831. doi: 10.1186/1471-2407-14-831.


Fertility drugs, reproductive strategies and ovarian cancer risk.

Tomao F, Lo Russo G, Spinelli GP, Stati V, Prete AA, Prinzi N, Sinjari M, Vici P, Papa A, Chiotti MS, Benedetti Panici P, Tomao S.

J Ovarian Res. 2014 May 8;7:51. doi: 10.1186/1757-2215-7-51. Review.


Use of fertility drugs and risk of ovarian cancer.

Diergaarde B, Kurta ML.

Curr Opin Obstet Gynecol. 2014 Jun;26(3):125-9. doi: 10.1097/GCO.0000000000000060. Review.


Long-term relationship of ovulation-stimulating drugs to breast cancer risk.

Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Ruggieri D, Trabert B, Lamb EJ.

Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):584-93. doi: 10.1158/1055-9965.EPI-13-0996.


Simultaneous serous cyst adenoma and ovarian pregnancy in an infertile woman.

Ebrahimi M, Akbari Asbagh F.

Int J Fertil Steril. 2014 Apr;8(1):85-90.


Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.

Kim HS, Kim TH, Chung HH, Song YS.

Br J Cancer. 2014 Apr 2;110(7):1878-90. doi: 10.1038/bjc.2014.29.


BMPR1B up-regulation via a miRNA binding site variation defines endometriosis susceptibility and CA125 levels.

Chang CY, Chen Y, Lai MT, Chang HW, Cheng J, Chan C, Chen CM, Lee SC, Lin YJ, Wan L, Tsai PW, Yang SH, Chung C, Sheu JJ, Tsai FJ.

PLoS One. 2013 Dec 5;8(12):e80630. doi: 10.1371/journal.pone.0080630.


ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.

Samartzis EP, Noske A, Dedes KJ, Fink D, Imesch P.

Int J Mol Sci. 2013 Sep 12;14(9):18824-49. doi: 10.3390/ijms140918824. Review.


Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.

Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Brinton LA.

Fertil Steril. 2013 Dec;100(6):1660-6. doi: 10.1016/j.fertnstert.2013.08.008.


Fertility drug use and the risk of ovarian tumors in infertile women: a case-control study.

Asante A, Leonard PH, Weaver AL, Goode EL, Jensen JR, Stewart EA, Coddington CC.

Fertil Steril. 2013 Jun;99(7):2031-6. doi: 10.1016/j.fertnstert.2013.02.010.

Items per page

Supplemental Content

Support Center